Trends and risk factors of hepatitis A in Catalonia after the introduction of a hepatitis A+B vaccination programme

J Viral Hepat. 2018 Sep;25(9):1001-1007. doi: 10.1111/jvh.12900. Epub 2018 Apr 26.

Abstract

At the end of 1998, universal hepatitis A+B vaccination of 12 year olds was introduced in Catalonia. The aim was to examine trends in hepatitis A during 2005-2015 and assess risk factors by age group. We carried out an observational epidemiological study of the incidence and risk factors of hepatitis A reported to the surveillance system. Information on exposure was recorded for each case for the 2-6 weeks before symptom onset. Spearman's coefficient was used to evaluate the trends of rates. The chi-square test was used to compare categorical. We studied 2621 hepatitis A cases; the age mean was 26.6 years (SD=18.2), and >50% of cases were in the 20-49 years age group. The incidence decreased from 3.28/100 000 in 2005 to 1.50/100 000 in 2015. The rate for women decreased over time (P = .008), but the reduction was not significant in men (P = .234). Men consistently had higher rates than women with the biggest difference being in the 20-34 years age group (rate 8.8 vs 2.8). The greatest risk factor was travel to an endemic country (42.1%) in the 0-19 years age group and male-to-male sexual contact (18.6%) in the 20-49 years age group. The case fatality rate in adults aged >49 years was 0.4%. In conclusion, the vaccination programme of preadolescents resulted in a reduction in hepatitis A cases. However, a significant amount of cases still appear in immigrants and men who have sex with men. Hepatitis A in adults is an emerging health problem that will require new strategies.

Keywords: epidemiology; hepatitis A; risk factor; surveillance; vaccine.

Publication types

  • Observational Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Child
  • Child, Preschool
  • Epidemiologic Studies
  • Female
  • Hepatitis A / epidemiology*
  • Hepatitis A / prevention & control*
  • Hepatitis A Vaccines / administration & dosage*
  • Hepatitis B Vaccines / administration & dosage
  • Humans
  • Immunization Programs*
  • Incidence
  • Infant
  • Infant, Newborn
  • Male
  • Middle Aged
  • Mortality
  • Risk Factors
  • Sex Factors
  • Spain / epidemiology
  • Vaccination / statistics & numerical data*
  • Young Adult

Substances

  • Hepatitis A Vaccines
  • Hepatitis B Vaccines